Various immunosuppressive synthetic drugs and biologics, such as salicylates, corticosteroids, tumor necrosis factor (TNF) blockers, and vedolizumab, are available as therapies for IBD, and many additional options are in the pipeline [3,4,5]. This evidence concerns the gene TNF and inflammatory bowel disease.